Leukemia News and Research

RSS
Leukemia (Leukaemia) is a cancer of the blood cells. It is the most common type of blood cancer and affects 10 times as many adults as children. Most people diagnosed with leukemia are over 50 years old. No one knows why some people develop leukemia and others do not. However, scientists have identified some risk factors for the disease. Most people who have known risk factors do not get leukemia, while many who do get the disease have none of these risk factors. During the early stages of leukemia, there may be no symptoms. Many of the symptoms of leukemia don't become apparent until a large number of normal blood cells are crowded out by leukemia cells.
Study reveals genetic variant linked to increased risk of leukemia in Hispanic/Latino children

Study reveals genetic variant linked to increased risk of leukemia in Hispanic/Latino children

Vitamin D shows promise in targeting aging's biological mechanisms, study finds

Vitamin D shows promise in targeting aging's biological mechanisms, study finds

Venetoclax combo opens new treatment path for incurable multiple myeloma

Venetoclax combo opens new treatment path for incurable multiple myeloma

Researchers create new platform to identify proteins for targeted treatment of disease

Researchers create new platform to identify proteins for targeted treatment of disease

Rising survival rates for AML patients over 65 after allogeneic hematopoietic stem cell transplant

Rising survival rates for AML patients over 65 after allogeneic hematopoietic stem cell transplant

California’s expanded health coverage for immigrants collides with Medicaid reviews

California’s expanded health coverage for immigrants collides with Medicaid reviews

Groundbreaking atlas maps over 80 blood stem cell types

Groundbreaking atlas maps over 80 blood stem cell types

Concomitant pharmacotherapy overcomes immunotherapy challenges in aggressive blood cancer

Concomitant pharmacotherapy overcomes immunotherapy challenges in aggressive blood cancer

The efficacy of the Mediterranean diet on health outcomes in adults with cancer

The efficacy of the Mediterranean diet on health outcomes in adults with cancer

New analysis sheds light on cancer incidence and mortality trends in the UK

New analysis sheds light on cancer incidence and mortality trends in the UK

Novel dual-target CAR T cell therapy shows promise in treating recurrent glioblastoma

Novel dual-target CAR T cell therapy shows promise in treating recurrent glioblastoma

Transformational $50 million gift from Kenneth C. Griffin to boost Sylvester's research footprint

Transformational $50 million gift from Kenneth C. Griffin to boost Sylvester's research footprint

European experts publish recommendations for treatment of acute lymphoblastic leukemia in adults

European experts publish recommendations for treatment of acute lymphoblastic leukemia in adults

Association of volatile aromatic compounds in blood with hearing impairment

Association of volatile aromatic compounds in blood with hearing impairment

Toxic gas that sterilizes medical devices prompts safety rule update

Toxic gas that sterilizes medical devices prompts safety rule update

Universal, essential biomarker identified for childhood neuroblastoma

Universal, essential biomarker identified for childhood neuroblastoma

Innovative therapy targets and destroys leukemia stem cells

Innovative therapy targets and destroys leukemia stem cells

CPRIT awards MD Anderson 16 grants to support cancer research and prevention

CPRIT awards MD Anderson 16 grants to support cancer research and prevention

Air quality and residential greenness influence childhood cancer development

Air quality and residential greenness influence childhood cancer development

Study reveals mechanism of drug targeting protein modification in tumor suppressor genes

Study reveals mechanism of drug targeting protein modification in tumor suppressor genes

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.